According to a press release from the company, Premia Spine has announced that it received FDA premarket approval for its Total Posterior Spine Facet Joint Replacement System.
Researchers found that patients with lumbar stenosis or degenerative spondylolisthesis treated with the Total Posterior Spine Joint Replacement System (n=115) showed better functional improvements, as well as fewer new or worsening neurologic deficits. They also experienced fewer postoperative injections, surgical interventions and failures of motion or fusion compared to patients treated with transforaminal
